Insurance and socioeconomic status do not explain racial disparities in breast cancer care

	Tweet

Racial disparities in the receipt of breast cancer care persist despite accounting for patients’ insurance and social and economic status. That is the conclusion of a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The findings suggest that greater efforts are needed to better understand disparities in breast cancer care and to ensure that all affected women receive equal and effective treatments.

Studies have demonstrated that black and Hispanic women are less likely to receive recommended breast cancer treatments than white women, but few studies have examined whether these differences in the receipt of breast cancer care are affected by patients’ socioeconomic status and health insurance. Rachel Freedman, MD, MPH, of the Dana-Farber Cancer Institute in Boston led a team that examined recommended breast cancer care (including localized therapy, hormone receptor testing, hormonal therapy, and chemotherapy) received by a large national sample of women with breast cancer. The researchers assessed whether insurance and socioeconomic factors were associated with any observed racial/ethnic differences in care.

The study included information from 662,117 white, black, and Hispanic women who were diagnosed with invasive breast cancer from 1998 to 2005 at National Cancer Data Base (NCDB) hospitals. (The NCDB is a registry that collects patient demographics, tumor characteristics, first course of treatment, and outcomes for cancer patients treated at U.S. hospitals.) Most women were white (86 percent), 10 percent were black, and 4 percent were Hispanic. Most had private insurance (51 percent) or Medicare (41 percent). 

Compared with white women, black women had 0.91 times lower odds of receiving recommended local therapy, 0.90 times lower odds of receiving hormonal therapy, and 0.87 times lower odds of receiving chemotherapy. Hispanic women were also less likely than white women to receive hormonal therapy. Hormone receptor testing did not differ by race/ethnicity. These modest racial disparities persisted even after accounting for insurance and socioeconomic status.

Despite efforts to eliminate disparities in cancer care in recent years, this study suggests that modest racial differences in the receipt of recommended breast cancer care still persist even after taking patients’ insurance and socioeconomic status into account. “Although health insurance expansion may resolve disparities in treatment by health insurance status, this study suggests that expansion alone is unlikely to have a major impact on disparities in breast cancer care among black women,” said Dr. Freedman. She noted that multifaceted efforts are needed to ensure that all women with breast cancer receive effective treatments.

###

Contact: Jennifer Beal

44-012-437-70633
Wiley-Blackwell

RELATED STORIES:
Women need evidence-based balanced information on HRT   Breast cancer risk higher in young smokers   Heart disease beats breast cancer as the biggest killer   Local Therapy and Survival in Breast Cancer   Breast cancer survivors face other cancer risks   Birth size is a marker of susceptibility to breast cancer later in life   Red Or White Wine? Both Are Equal in Terms of Breast-Cancer Risk   Big Bias In Who Gets Screened for Breast Cancer   FDA OKs Invitrogen genetic test for breast cancer   Girls with family history of breast disease should avoid alcohol   Combination overcomes breast cancer resistance to herceptin   Kinetic variable most useful for identifying malignant MRI-detected breast lesions identified   Targeted Immunotherapy: Metastatic Breast, Pancreatic Cancers   Researchers develop standard of care for breast cancer survivors with lymphedema   Long-term tamoxifen boosts breast cancer survival   Overweight and obese women at greater risk of breast cancer recurrence   Anti-estrogen Drug Therapy Reduces Risk of Invasive Breast Cancer in Older Women   Ethnic breast cancer gap tied to mammography rates   Extract from Scutellaria Barbata may treat breast cancer   Women not following through with recommended breast screening MRI   New Way of Expanding Cancer Screening for Minority Women   Declining breast cancer incidence in Canada with declining HRT usage

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]